84 related articles for article (PubMed ID: 20040646)
1. Low level (below cutoff) of anti-cyclic citrullinated peptide test results in diagnosis of rheumatoid arthritis in a high-risk population.
Kim DA; Kim TY
J Rheumatol; 2010 Jan; 37(1):208. PubMed ID: 20040646
[No Abstract] [Full Text] [Related]
2. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Mofidi M; Moghadam A
Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
[No Abstract] [Full Text] [Related]
5. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
[TBL] [Abstract][Full Text] [Related]
6. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
[TBL] [Abstract][Full Text] [Related]
7. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
Jansen TL
Ned Tijdschr Geneeskd; 2003 Apr; 147(15):729-30; author reply 730-1. PubMed ID: 12722537
[No Abstract] [Full Text] [Related]
8. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S
Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
[TBL] [Abstract][Full Text] [Related]
9. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
van Venrooij WJ; van de Putte LB; van den Hoogen FH
Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446
[No Abstract] [Full Text] [Related]
10. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
[TBL] [Abstract][Full Text] [Related]
11. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
van Venrooij WJ; van de Putte LB
Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
[TBL] [Abstract][Full Text] [Related]
12. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
13. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis].
Tant L; Steinfeld S
Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
Vallbracht I; Rieber J; Oppermann M; Förger F; Siebert U; Helmke K
Ann Rheum Dis; 2004 Sep; 63(9):1079-84. PubMed ID: 15308516
[TBL] [Abstract][Full Text] [Related]
15. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
[TBL] [Abstract][Full Text] [Related]
17. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
[No Abstract] [Full Text] [Related]
18. [Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis].
Araki C; Hayashi N; Moriyama M; Morinobu S; Mukai M; Koshiba M; Kawano S; Kumagai S
Rinsho Byori; 2004 Dec; 52(12):966-72. PubMed ID: 15675342
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis: a meta-analysis].
Huang QS; Wan LG; Luo ZQ; Le AP; Wang WQ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2182-7. PubMed ID: 17064503
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]